clinical trial · NCT07244003
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.·phase4·recruiting·n = 430
T2DM (Type 2 Diabetes Mellitus)MetforminTriple Therapy of Other Oral Antidiabetic Drugsganagliflozinliraglutide
brief summary
The main objective of this study is to compare the efficacy and safety of the triple combination therapy of Met/SGLT-2i/GLP-1RA or other oral antidiabetic drugs in patients with type 2 diabetes exhibiting poor glycemic control.
started
Mar 29, 2025
primary completion
Dec 31, 2027
completion
Jun 30, 2028
last updated
Nov 24, 2025
official title
Efficacy and Safety of the Triple Combination Therapy of Met/SGLT-2i/GLP-1RA or Other Oral Antidiabetic Drugs in Patients With Type 2 Diabetes Exhibiting Poor Glycemic Control
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol